Gene · 29927
Papers2,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The subset of peroxisomal tail-anchored proteins do not reach peroxisomes via ER, instead mitochondria can be involved. | PLoS One | 2023 | 38039321 | PubTator, text mining | PubMed |
| Two sides of the same coin: a complex presentation of autosomal dominant tubulointerstitial kidney diseases: a literature review and case reports. | Front Pediatr | 2023 | 38027261 | PubTator, text mining | PubMed |
| Cell-selective proteomics reveal novel effectors secreted by an obligate intracellular bacterial pathogen. | bioRxiv | 2023 | 38014272 | PubTator, text mining | PubMed |
Screening of Crucial Cytosolicproteins Interconnecting the Endoplasmic Reticulum and Mitochondria in Parkinson's Disease and the Impact of Anti-Parkinson Drugs in the Preservation of Organelle Connectivity. | Brain Sci | 2023 | 38002511 | PubTator, text mining | PubMed |
| Molecular view of ER membrane remodeling by the Sec61/TRAP translocon. | EMBO Rep | 2023 | 37983950 | PubTator, text mining | PubMed |
| Transmembrane Helices 7 and 8 Confer Aggregation Sensitivity to the Cystic Fibrosis Transmembrane Conductance Regulator. | Int J Mol Sci | 2023 | 37958724 | PubTator, text mining | PubMed |
| Prognostic significance of serum miR-18a-5p in severe COVID-19 Egyptian patients. | J Genet Eng Biotechnol | 2023 | 37953403 | PubTator, text mining | PubMed |
| EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma. | Acta Neuropathol Commun | 2023 | 37936247 | PubTator, text mining | PubMed |
| SLC3A2 N-glycosylation and Golgi remodeling regulate SLC7A amino acid exchangers and stress mitigation. | J Biol Chem | 2023 | 37918808 | PubTator, text mining | PubMed |
| A dual sgRNA library design to probe genetic modifiers using genome-wide CRISPRi screens. | BMC Genomics | 2023 | 37904134 | PubTator, text mining | PubMed |
| Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma. | Biomedicines | 2023 | 37893092 | PubTator, text mining | PubMed |
| Unraveling the Complexity of Childhood Polycystic Kidney Disease: A Case Study of Three Sisters. | Children (Basel) | 2023 | 37892363 | PubTator, text mining | PubMed |
| Pathogenic signal peptide variants in the human genome. | NAR Genom Bioinform | 2023 | 37859801 | PubTator, text mining | PubMed |
| Design of Synthetic Surrogates for the Macrolactone Linker Motif in Coibamide A. | ACS Med Chem Lett | 2023 | 37849553 | PubTator, text mining | PubMed |
| Unveiling the Hidden Power of Uromodulin: A Promising Potential Biomarker for Kidney Diseases. | Diagnostics (Basel) | 2023 | 37835820 | PubTator, text mining | PubMed |
| Amyloid Precursor Protein and Alzheimer's Disease. | Int J Mol Sci | 2023 | 37834241 | PubTator, text mining | PubMed |
An Intrabody against B-Cell Receptor-Associated Protein 31 (BAP31) Suppresses the Glycosylation of the Epithelial Cell-Adhesion Molecule (EpCAM) via Affecting the Formation of the Sec61-Translocon-Associated Protein (TRAP) Complex. | Int J Mol Sci | 2023 | 37834237 | PubTator, text mining | PubMed |
| SEC61 translocon subunit gamma enhances low-dose cisplatin-induced cancer-stem cell properties of head and neck squamous cell carcinoma via enhancing Ca2+-mediated autophagy. | J Dent Sci | 2023 | 37799908 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens and their applications in infectious disease. | Front Genome Ed | 2023 | 37794981 | PubTator, text mining | PubMed |
| Evaluating the prevalence of inborn errors of immunity in adults with chronic immune thrombocytopenia or Evans syndrome. | Blood Adv | 2023 | 37792884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/29927/papers?page=7